SANOFICONRNSESanofi Consumer Healthcare India Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Fri, 10 Oct, 2025 · 15:53 IST

CFO Narahari Naidu resigns effective October 15, 2025

Cfo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.6%Reaction day
₹4680.00
prior close
₹4640.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.5%-1.1% vs market
Pharmaceuticals peers, median of 152sector-0.7%-0.9% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.3
15m
-0.1
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.6-0.5-1.1-0.7-0.9
Next day
+0.6-1.7+2.3-1.2+1.9
2d
+0.4-0.7+1.1-1.1+1.6
3d
+0.6-0.2+0.7-1.0+1.6
4d
+0.4-0.7+1.1-1.4+1.8
5d
+0.3+0.3-0.0-1.1+1.4
1w
-0.6+0.9-1.5-1.0+0.4
15d
+3.9+1.4+2.4-1.0+4.8
1m
+6.7+0.3+6.4-2.8+9.5
2m
-2.4-4.5+2.1-5.1+2.8
3m
-8.9-7.4-1.4-8.5-0.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 152Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Narahari Naidu resigned as Chief Financial Officer and Key Managerial Personnel to pursue new career opportunities outside the organisation. His last working day and the effective date of resignation were October 15, 2025. The filing does not name a successor.

Likely market impact

The departure creates a finance leadership vacancy and may add short-term management uncertainty; no successor was disclosed.